Background
The wild cavy or guinea pig occurs in South America from
Columbia and Venezuela southward to Brazil and northern
Argentina. Guinea pigs inhabit a wide variety of habitat such
as rocky regions, savannas, the edge of forests and swamps.
In the wild forms the hair is fairly course and long but in
the domestic guinea pigs it varies from smooth and short to
smooth and long to course and short in some for-ms the hair
even radiates in rosettes. Although domestic guinea pigs
exhibit an extremely wide range of color, the wild forms are
generally gray or brownish. Guinea pigs have stocky bodies,
fairly short hind legs, short ears and lack a tail. The hind
feet are long with sharp claws. Guinea pigs in the wild are
burrowing animals. Sometimes they live in the abandoned
burrows of other animals. They generally associate in small
groups, usually 5 to 10 individuals, and are always prepared
to flee at the slightest indication of danger. They are
nocturnal feeders and the diet consists of various forms of
vegetation. South American native Indian tribes, particularly
the Incas, raised them for food since their flesh is of
excellent quality. During the second world war a project
conducted by the Navy investigating the palatability and
nutritional value of various laboratory species for the human
population determined that the Guinea Pig was the most
desirable of the common species. The Guinea Pig was
introduced into Europe in the 16th Century by 1 the Dutch and
their use spread quickly throughout the Continent. They were
known by a variety of common names: "Sea Pig," "Barbary
Rabbit," or "Little Sea Pig". The name Guinea Pig has become
synonymous with of "experimental subject" in the that English
language.
The unique characteristics of the Guinea Pig that differ
from other experimental animals include the highly developed
young at birth due to the long gestation period and the udder
type mammary gland. The young at birth are fully developed.
Their eyes are open, they are fully haired, and completely
mobile. They begin eating solid food at approximately 2 to 3
days of age and can be easily weaned at 10 days. The mammary
gland consists of a two section udder, each section with a
single teat. Milking machines have been easily developed to
utilize this udder for milk secretion research studies. The
Guinea Pig is unable to synthesize an adequate supply of
vitamin C and therefore must be supplied with either a
supplement or a fortified diet.
Handling techniques
Guinea Pigs are probably the easiest of all the common
laboratory animals to handle and restrain. They are nervous,
high-strung animals compared to other laboratory rodents and
are rather noisy. These sounds consist mainly of squealing,
whistling, and grunting sounds. To restrain a Guinea Pig,
grasp the animal around the thoracic area from above with the
thumb and forefinger right behind the front legs and lift.
The other hand should be placed under the Guinea Pig's hind
quarters for support. Failure to restrain and support the
hind quarters may result in injury to the Guinea Pig as well
as injuries to the operator from scratching. Guinea Pigs
rarely if ever bite. Since they have short legs and heavy
bodies they are unable to climb or jump. In some instances
they are housed in open-top cages or pens because of this
inability to escape. IP injection of the Guinea Pig is
accomplished by restraining the animal as indicated above and
injecting in one of the lower quadrants of the abdomen.
Subcutaneous injection can be accomplished by lifting the
loose skin of the back, particularly over the neck and
shoulder, and injecting under the fold. The Guinea Pig may be
bled by heart puncture, anterior vena cava puncture, or small
samples may be obtained from the medical canthus of the eye.
Repeated blood sampling utilizing these methods can be
accomplished if a suitable period of two or three days
between drawings is allowed. In males the lateral vein the
penis may be used for IV injections.
Experimental Uses
As the common usage of the term Guinea Pig implies, this
species is widely employed as a research animal. The Guinea
Pig has been used in antibody production, tumorigenesis,
nutrition, genetics, radiation research, and dental studies
including antibacterial action of saliva and production. The
Guinea Pig is used extensively in laboratory studies of
disease, nutrition and heredity, and in, development of sera.
The Guinea Pig has been widely employed in biomedical
research since 1780. Lavoisier used the cavy for measuring
heat production. Much of the work relating to the discovery
of Vitamin C, the diagnosis of tuberculosis, and the research
on anaphylaxis has been performed in this species.
Strains and Sources
The majority of Guinea Pigs used in this country are
random bred Guinea Pigs. Although inbreeding of Guinea Pigs
was initiated at the Bureau of Animal Industry facility near
Washington, D.C., in 1897, only two inbred strains, 2 and 13,
still exist and these are not widely used,. The Guinea Pig,
because of its large size and caging requirements, is not as
widely used as the other laboratory species but does lend
itself as an animal model to many research studies. When
selecting a particular inbred or many research studies. When
selecting a particular inbred or random bred strain of Guinea
Pig for utilization, the availability and source should be
closely considered. Because of its limited use, only a small
number of breeders supply Guinea Pigs. The investigator is
encouraged to investigate fully the suggested commercial
sources before utilizing the animals these sources. As the
quality of the animal received and supplied may vary greatly
from one supplier to another, once a particular strain and
supplier is selected they should be utilized throughout the
entire study. Strain differences between individual breeders
may be considerable. Therefore one supplier should be used if
possible.
|
PHYSIOLOGICAL AND GENERAL DATA
|
| Breeding season |
no definite season |
| Estrous cycle |
16 ½ days (range of 16 to 19 days) |
| Estrous duration |
6 to 11 hours |
| Gestation period |
63 days (range of 59 to 72) |
| Birth weight |
70 - 100 grams |
| Litter size |
2 to 5 |
| Weaning weight |
150-200 grams (14-21 days) |
| Male breeding age |
3 to 4 months |
| Female breeding age |
2 to 3 months |
| Adult Male weight |
1000 to 1200 grams |
| Adult female weight |
850 to 900 grams |
| Male reproductive life span |
4 years |
| Female reproductive life span |
1.5 to 4 years (4-5 litters) |
| Body temperature |
39.1'C (range of 38.4 to 39.8) |
| Diploid number |
64 |
| Respiration rate |
90 per minute |
| Food consumption |
6 grams of feed/100 grams of body weight/day |
| Water consumption |
10 ml/100 grams of body weight/day |
| GI transit time |
13-30 hours |
| Heart rate |
280 (range 260 to 400) |
Guinea Pig
|
ANESTHETIC, ANALGESIC
|
Dose
|
Back to Top
|
| ACETAMINOPHEN (TYLENOL) |
269 MG/KG IP *7 |
NONSTEROIDAL ANTI-INFLAMMATORY |
| ACETHYLSALICYLICATE ACID (ASPIRIN) |
269 IP/300 PO/20 SC MG/KG |
NONSTEROIDAL ANTI-INFLAMMATORY |
| ACETYLPROMAZINE (ACEPROMAZINE) - DOSAGE |
1-2 MG/KG IM |
TRANQUILIZER-PHENOTHIAZINE |
| BUPIVACAINE (MARCAINE) |
AS NEEDED |
LOCAL ANESTHETIC |
| BUPRENORPHINE (BUPRENEX) |
0.05 MG/KG SC* Q8-12H**/**** |
NARCOTIC AGONIST-ANTAGONIST V |
| CHLORAL HYDRATE 5% |
200-400 MG/KG IP |
HYPNOTIC |
| DIAZAPAM (VALIUM) DOSAGE |
2.5 MG/KG IP * |
TRANQUILIZER - BENZODIAZEPINE IV |
| DIAZAPAM - DURATION TO EFFECT |
1-2 HOURS |
TRANQUILIZER - BENZODIAZEPINE IV |
| DIAZAPAM - TIME TO EFFECT |
2-5/5 MIN |
TRANQUILIZER - BENZODIAZEPINE IV |
| DOXAPRAM -DOPRAM V-DOSAGE |
5MG/KG IV*** |
ANALEPTIC |
| FENTANYL/DROPERIDOL (INNOVAR-VET)-DOSAGE |
0.66-0.88 ML/KG IM * (CAUTION) |
NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE
TRANQUILIZER II |
| FENTANYL/DROPERDOL - DURATION EFFECT |
20-40 MIN |
NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE
TRANQUILIZER II |
| FENTANYL/DROPERIDOL - TIME TO EFFECT |
15/5 MIN |
NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE
TRANQUILIZER II |
| FENTANYL/DROPERIDOL/DIAZEPAM-DOSE |
1 ML/KG IM/2.5 MG/KG IP * |
NEUROLEPTANALGESIC, NARCOTIC/BUTYROPHENONE
TRANQUILIZER,BUTYROPHENONE II |
| KETAMINE (KETASET, VETALAR) - DOSAGE |
50-200 MG/KG IM * |
DISSOCIATIVE |
| KETAMINE-ACEPROMAZINE |
125/5 MG/KG IM*/** |
DISSOCIATIVE/TRANQUILIZER |
| KETAMINE-XYLAZINE (ROMPUN) |
40-100 IM/4-5 SC IM MG/KG/ OR 87/13 MG/KG IM* |
DISSOCIATIVE/ANALGESIC |
| KETAMINE-DIAZEPAM (VALIUM) |
100/5 MG/KG IM*/** |
DISSOCIATIVE/TRANQUILIZER |
| MEPERIDINE (DEMEROL) |
20 MG/KG IPIMSC Q2-3H |
NARCOTIC II |
| METHOHEXITAL (BREVITAL/BREVANE) |
31 MG/KG IP ** |
ULTRA SHORT BARBITUATE IV |
| MORPHINE |
10 MG/KG IM SC * Q2-4H ** |
NARCOTIC II |
| PENTAZOCINE (TALWIN-V) |
10 MG/KG SC IM IV |
NON-NARCOTIC ANALGESIC IV |
| PENTOBARBITAL Na (NEMBUTAL) |
35-40 MG/KG IM IP* |
BARBITUATE SHORT II |
| PHENCYCLADINE - DOSAGE |
3 MG/KG IM |
TRANQUILIZER |
| PHENCYCLADINE - DURATION |
20-60 MIN |
TRANQUILIZER |
| PHENCYCLADINE - TIME EFFECT |
5-10 MIN |
TRANQUILIZER |
| PHENCYLADINE - TIME FULL RECOVERY |
2 HOURS |
TRANQUILIZER |
| PHENYLBUTAZONE (BUTAZOLDIN) |
150 MG/KG IP *7 |
NONSTEROIDAL ANTI-INFLAMMATORY |
| THIAMYLAL (SURITAL) |
20-50 MG/KG IV,IP |
BARBITUATE ULTRASHORT III |
| THIOPENTAL (PENTOTHAL) |
20-55 MG/KG IV IP // 20 IV **** |
BARBITUATE ULTRASHORT III |
| XYLAZINE (ROMPUN)- DOSAGE |
3-5 MG/KG IM |
ALPHA-2-ADRENERGIC AGONIST SEDATIVE, ANAGESIC, MUSCLE
RELAXANT |
|
ANESTHETIC GAS
|
Dose
|
Back to Top
|
| HALOTHANE - MAC |
0.95 |
INHALANT |
| ISOFLURANE - MAC |
|
INHALANT |
| METHOXYFLURANE - MAC |
0.22 |
INHALANT |
| NITROUS OXIDE-MAC |
150 |
INHALANT |
|
ANTI-INFLAMMATORY
|
Dose
|
Back to Top
|
| DEXAMETHASONE (AZIUM) |
0.06 MG SC IM IV IP |
STEROID |
| PREDNISONE (METICORTIN) |
0.05-0.22 MG SC IM |
STEROID |
|
ANTIBIOTIC
|
Dose
|
Back to Top
|
| AMOXICILLIN |
TOXIC** |
ANTIBIOTIC |
| AMPICILLIN (POLYFLEX) |
TOXIC**/*** |
BETA LACTAM ANTIBIOTIC |
| BACITRACIN |
NEVER |
ANTIBIOTIC |
| CEPHALORIDINE (LORIDINE) |
25 MG/KG IM Q24H**/*** |
BETA LACTAM ANTIBIOTIC |
| CHLORAMPHENICOL PALMITATE (CHLOROMYCETIN) |
50 MMG/KG PO TID *** |
BACTERIAL STATIC BROAD SPEC. |
| CHLORAMPHENICOL SUCCINATE (CHLOROMYCETIN) |
20 MG/KG IM Q24H **/*** |
BACTERIAL STATIC BROAD SPEC. |
| ERYTHROMYCIN |
NEVER |
BACTERIAL |
| GENTAMICIN (GENTOCIN) |
5 MG/KG SC IM SID *** 14D* |
AMINOGLYCOSIDES |
| GRISEOFULVIN (FULVICIN U/F) |
25 MG/KG PO IN FOOD *** |
ANTIFUNGAL |
| NEOMYCIN (BIOSOL) |
10 PO/ 30 SC MG/KG Q24H **// OR 5 PO Q12H/30 SC Q24H
MG/KG *** |
DIARRHEA |
| OXYTETRACYCLINE (LIQUAMYCIN) |
TOXIC **/*** |
BACTERIAL STATIC BROAD SPEC. |
| PENICILLIN |
NEVER |
ANITBIOTIC |
| PENICILLIN -
BENZATHIN/PROCAINE(BICILLIN)(FLOCILLIN) |
BACTERIAL |
| STREPTOMYCIN (BIOTEC) |
NEVER |
BACTERIAL |
| SULFAMETHAZINE OR SULFAMERAZINE |
DW 1 MG/ML *** |
BACT. COCCIDIA,CIT,B |
| SULFAQUINOXALINE (SULQUIN) |
DW 1 MG/ML *** |
EIMERIA,KLOS. PAST. |
| TETRACYCLINES |
TOXIC *** |
BACTERIAL STATIC BROAD SPEC//FROG RED LEG |
| TRIMETHOPRIM (40MG/ML)/SULPHADOXINE (200MG/ML)
(TRIBRISSEN) |
0.5ML/KG SC**// OR 30 MG/KG SC Q24H (YOUNG 15 MG/KG
SC Q24H)*** |
TRIMETHOPRIM / SULPHONAMIDE |
| TYLOSIN |
66 MG/L 21D |
MACROLIDES |
|
ANTICHOLINERGIC
|
Dose
|
Back to Top
|
| ATROPINE - DOSAGE |
0.05 MG/KG SC IM**/*** |
ANTICHOLINERGIC |
| ATROPINE - DURATION EFFECT |
15 MIN |
ANTICHOLINERGIC |
| ATROPINE - TIME TO EFFECT |
10 MIN |
ANTICHOLINERGIC |
|
ANTIPARASITIC
|
Dose
|
Back to Top
|
| CARBARYL POWDER (DIRYL) |
5 D |
ECTOPARASITIC |
| DICHLORVOS (TASK) |
500 MG/KG IN FEED/24H |
ECTOPARASITIC-SYPH, HETER |
| DICHLORVOS (VOPONA STRIPS) |
STRIP 48H/WK // OR 1/5 OVER CAGE FOR 3D*** |
ECTOPARASITIC |
| FURANACE |
NEVER |
BACTERIAL |
| IVERMECTIN (IVOMEC) |
200 MCG/KG PO SC*** |
ANTI-NEMATODES/ECTOPARASITIC |
| MEBENDAZOLE (TELMIN) |
10 MG/KG PO 5D*** |
NEMATODIASIS COSMOCE |
| NICLOSAMIDE (YOMESAN) |
100 MG/KG PO*** |
CESTODES-HYMENOLEPSIS |
| PIPERAZINE |
100 MG/KG PO***//3 MG/ML IN WATER + SYRUP *9 |
ANTI-NEMATODES-SYPHACIA & HET & PINWORMS |
| SUCCINYSULFATHIAZOLE |
1% IN WATER |
EIMERIA |
| THIABENDAZOLE (TBZ; OMIZOLE) |
100 MG/KG PO 5D*** |
ANTI-NEMATODES - OPHIDAS |
|
HORMONE
|
Dose
|
Back to Top
|
| OXYTOCIN |
0.2-3 UNITS/KG SC IM *9 |
UTERINE/MILK HORM. |
|
EUTHANASIA
|
Dose
|
Back to Top
|
| Sodium pentobarbital |
150 mg/kg IP |
Controlled substance |
| Halothane |
To effect |
High Concentration, Rapid flow |
| Isoflurane |
To effect |
High Concentration, Rapid flow |
| CO2 |
To effect |
Requires some other method to ensure death |
| CO |
To effect |
See hazards under euthanasia training |
| Potassium chloride |
1-2 mmol/kg IV IC |
Requires general anesthesia |
| Cervical dislocation |
Unacceptable |
Too much musculature |
| Decapitation |
Conditionally acceptable |
Requires scientific justification by user and
approval of IACUC, Requires special training and
monitoring, Hazard, requires special training for hazard,
Equipment has to be maintained. Only on very young. |
| Chloral hydrate |
Unacceptable |
Not used in Guinea Pigs |
|
Notes
|
Back to Top
|
*= Anesthesia and Analgesia in Laboratory
Animals: American College of Laboratory Animal Medicine:
1990
** = Laboratory Animal Anesthesia: Flecknell: 1989
*** = Drug Dosages for Small Mammals: McKellar:
1989
****= Recognition and Alleviation of Pain and
Distress in Laboratory Animals: NRC: 1992
*5= Current Veterinary Therapy 2 Food Animal
Practice
*6 = University of Calif., San Fran., Morrish
*7 = Basic Care of Experimental Animals
*8= Therapeutic Guide and Anesthesia, O'Harndley
*9= The Biology and Medicine of Rabbits and
Rodents
*10= ???????? Continuing Education Vol. 5, No. 4,
April 1992
*11 = USUHS Formulary
*12 = LAB ANIMAL OCT 91 PAGE 34
*13= ANESTHESIA AND ANALGESIC DOSES, SCHAEFFER,
KNOXVILLE, TN |
|